A detailed history of Grove Bank & Trust transactions in Amgen Inc stock. As of the latest transaction made, Grove Bank & Trust holds 2,657 shares of AMGN stock, worth $782,566. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,657
Previous 2,552 4.11%
Holding current value
$782,566
Previous $797,000 7.4%
% of portfolio
0.13%
Previous 0.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$309.38 - $337.38 $32,484 - $35,424
105 Added 4.11%
2,657 $856,000
Q2 2024

Jul 24, 2024

SELL
$262.75 - $319.31 $32,843 - $39,913
-125 Reduced 4.67%
2,552 $797,000
Q1 2024

Apr 30, 2024

SELL
$268.87 - $324.56 $557,098 - $672,488
-2,072 Reduced 43.63%
2,677 $761,000
Q4 2023

Jan 30, 2024

SELL
$255.7 - $288.46 $366,673 - $413,651
-1,434 Reduced 23.19%
4,749 $1.37 Million
Q3 2023

Oct 30, 2023

BUY
$218.65 - $271.46 $131,845 - $163,690
603 Added 10.81%
6,183 $1.66 Million
Q2 2023

Jul 27, 2023

BUY
$214.27 - $253.37 $217,698 - $257,423
1,016 Added 22.26%
5,580 $1.24 Million
Q1 2023

May 10, 2023

BUY
$225.79 - $275.2 $129,603 - $157,964
574 Added 14.39%
4,564 $1.1 Million
Q4 2022

Feb 03, 2023

SELL
$229.03 - $291.01 $181,391 - $230,479
-792 Reduced 16.56%
3,990 $1.05 Million
Q3 2022

Oct 28, 2022

BUY
$224.46 - $253.15 $136,471 - $153,915
608 Added 14.57%
4,782 $1.08 Million
Q2 2022

Jul 29, 2022

BUY
$230.71 - $256.74 $26,993 - $30,038
117 Added 2.88%
4,174 $1.02 Million
Q1 2022

Apr 22, 2022

BUY
$219.27 - $242.57 $143,841 - $159,125
656 Added 19.29%
4,057 $981,000
Q4 2021

Jan 31, 2022

BUY
$198.88 - $227.6 $42,759 - $48,934
215 Added 6.75%
3,401 $765,000
Q3 2021

Oct 28, 2021

SELL
$212.27 - $248.7 $10,401 - $12,186
-49 Reduced 1.51%
3,186 $678,000
Q2 2021

Jul 28, 2021

BUY
$233.58 - $259.14 $14,715 - $16,325
63 Added 1.99%
3,235 $789,000
Q1 2021

Apr 23, 2021

BUY
$221.91 - $258.6 $1,775 - $2,068
8 Added 0.25%
3,172 $789,000
Q4 2020

Feb 03, 2021

BUY
$216.38 - $257.67 $28,778 - $34,270
133 Added 4.39%
3,164 $727,000
Q3 2020

Oct 30, 2020

SELL
$234.65 - $260.95 $13,140 - $14,613
-56 Reduced 1.81%
3,031 $770,000
Q2 2020

Jul 31, 2020

BUY
$197.81 - $242.74 $77,739 - $95,396
393 Added 14.59%
3,087 $728,000
Q1 2020

May 05, 2020

SELL
$182.24 - $241.7 $2,186 - $2,900
-12 Reduced 0.44%
2,694 $546,000
Q4 2019

Feb 11, 2020

BUY
$189.21 - $243.2 $39,734 - $51,072
210 Added 8.41%
2,706 $652,000
Q3 2019

Oct 30, 2019

BUY
$174.11 - $208.62 $49,273 - $59,039
283 Added 12.79%
2,496 $483,000
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $1,667 - $1,954
-10 Reduced 0.45%
2,213 $408,000
Q1 2019

Apr 26, 2019

BUY
$180.87 - $203.88 $71,443 - $80,532
395 Added 21.61%
2,223 $422,000
Q4 2018

Feb 13, 2019

BUY
$178.4 - $208.25 $36,928 - $43,107
207 Added 12.77%
1,828 $356,000
Q3 2018

Nov 07, 2018

SELL
$185.29 - $208.89 $19,826 - $22,351
-107 Reduced 6.19%
1,621 $336,000
Q2 2018

Aug 03, 2018

SELL
$166.05 - $186.51 $5,479 - $6,154
-33 Reduced 1.87%
1,728 $319,000
Q1 2018

May 07, 2018

SELL
$169.43 - $198.0 $7,285 - $8,514
-43 Reduced 2.38%
1,761 $300,000
Q4 2017

Feb 02, 2018

BUY
$168.79 - $188.59 $5,570 - $6,223
33 Added 1.86%
1,804 $314,000
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $296,270 - $338,261
1,771
1,771 $330,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Grove Bank & Trust Portfolio

Follow Grove Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grove Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Grove Bank & Trust with notifications on news.